Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes
(IAI Trial)
Recruiting in Palo Alto (17 mi)
+18 other locations
AC
Overseen byAndrew Combs, MD, PhD
Age: 18+
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: ProteoGenix, Inc.
No Placebo Group
Trial Summary
What is the purpose of this trial?
The purpose of this study is to collect clinical specimens and corresponding clinical data to develop a non-invasive test for detection of intra-amniotic infection and prediction of preterm birth in women and intact amniotic membranes. The specimens collected will be used to develop a specific biomarker panel and algorithm using immunoassays for optimal detection of intra-amniotic infection in women with preterm labor and intact amniotic membranes.
Research Team
AC
Andrew Combs, MD, PhD
Principal Investigator
Obstetrix Medical Group of California
Eligibility Criteria
Inclusion Criteria
Subject is greater than or equal to 18 years of age
Subject has singleton gestation
Subject has fetus with gestational age greater than or equal to 22 0/7 weeks and less than or equal to 36 6/7 weeks
See 6 more
Treatment Details
Interventions
- Non-invasive Test (Biomarker Panel)
Find a Clinic Near You
Who Is Running the Clinical Trial?
ProteoGenix, Inc.
Lead Sponsor
Trials
2
Recruited
980+
Obstetrix Medical Group
Industry Sponsor
Trials
17
Recruited
8,100+